在哮喘治疗中，就安全性和耐受性而言，固定复方制剂有哪些优势？ - Suppr

Suppr

超能文献

[Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].

作者信息

Virchow C

机构信息

Institut Klinik und Poliklinik für Innere Medizin, Abt. für Pneumologie, Universität Rostock.

出版信息

Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S376-80. doi: 10.1055/s-0029-1243045. Epub 2009 Nov 25.

DOI:10.1055/s-0029-1243045

PMID:19941240

Abstract

摘要

相似文献

[Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].

Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S376-80. doi: 10.1055/s-0029-1243045. Epub 2009 Nov 25.

[Do fixed combinations increase effectiveness in asthma bronchiale?].

Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S372-5. doi: 10.1055/s-0029-1243044. Epub 2009 Nov 25.

[Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?].

Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S381-5. doi: 10.1055/s-0029-1243046. Epub 2009 Nov 25.

Inhaled corticosteroid therapy in asthma: a balancing act.

Ann Allergy Asthma Immunol. 1999 Mar;82(3):229-30. doi: 10.1016/S1081-1206(10)62602-6.

Beta agonist use during asthma exacerbations: how much is too much?

N Z Med J. 2011 Apr 15;124(1332):77-80.

Call for withdrawal of LABA single-therapy inhaler in asthma.

Lancet. 2010 Sep 4;376(9743):750-1. doi: 10.1016/S0140-6736(10)61158-0.

On-demand relief treatment for asthma.

Lancet. 2001 Jun 9;357(9271):1882; author reply 1882-3. doi: 10.1016/S0140-6736(00)04983-7.

[Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study].

Pneumologie. 1999 Apr;53(4):210-2.

[Interaction between inhaled corticosteroids and long-acting beta-2-agonists].

Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S386-9. doi: 10.1055/s-0029-1243047. Epub 2009 Nov 25.

FDA panel: ban 2 popular asthma drugs.

JAMA. 2009 Jan 28;301(4):365-6. doi: 10.1001/jama.2008.991.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].

Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S376-80. doi: 10.1055/s-0029-1243045. Epub 2009 Nov 25.

[Do fixed combinations increase effectiveness in asthma bronchiale?].

Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S372-5. doi: 10.1055/s-0029-1243044. Epub 2009 Nov 25.

[Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?].

Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S381-5. doi: 10.1055/s-0029-1243046. Epub 2009 Nov 25.

Inhaled corticosteroid therapy in asthma: a balancing act.

Ann Allergy Asthma Immunol. 1999 Mar;82(3):229-30. doi: 10.1016/S1081-1206(10)62602-6.

Beta agonist use during asthma exacerbations: how much is too much?

N Z Med J. 2011 Apr 15;124(1332):77-80.

Call for withdrawal of LABA single-therapy inhaler in asthma.

Lancet. 2010 Sep 4;376(9743):750-1. doi: 10.1016/S0140-6736(10)61158-0.

On-demand relief treatment for asthma.

Lancet. 2001 Jun 9;357(9271):1882; author reply 1882-3. doi: 10.1016/S0140-6736(00)04983-7.

[Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study].

Pneumologie. 1999 Apr;53(4):210-2.

[Interaction between inhaled corticosteroids and long-acting beta-2-agonists].

Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S386-9. doi: 10.1055/s-0029-1243047. Epub 2009 Nov 25.

FDA panel: ban 2 popular asthma drugs.

JAMA. 2009 Jan 28;301(4):365-6. doi: 10.1001/jama.2008.991.